242 related articles for article (PubMed ID: 20635406)
1. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations.
Cox JJ; Sheynin J; Shorer Z; Reimann F; Nicholas AK; Zubovic L; Baralle M; Wraige E; Manor E; Levy J; Woods CG; Parvari R
Hum Mutat; 2010 Sep; 31(9):E1670-86. PubMed ID: 20635406
[TBL] [Abstract][Full Text] [Related]
2. Novel
Sun J; Li L; Yang L; Duan G; Ma T; Li N; Liu Y; Yao J; Liu JY; Zhang X
Mol Pain; 2020; 16():1744806920923881. PubMed ID: 32420800
[TBL] [Abstract][Full Text] [Related]
3. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
4. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.
Drenth JP; Waxman SG
J Clin Invest; 2007 Dec; 117(12):3603-9. PubMed ID: 18060017
[TBL] [Abstract][Full Text] [Related]
5. An SCN9A channelopathy causes congenital inability to experience pain.
Cox JJ; Reimann F; Nicholas AK; Thornton G; Roberts E; Springell K; Karbani G; Jafri H; Mannan J; Raashid Y; Al-Gazali L; Hamamy H; Valente EM; Gorman S; Williams R; McHale DP; Wood JN; Gribble FM; Woods CG
Nature; 2006 Dec; 444(7121):894-8. PubMed ID: 17167479
[TBL] [Abstract][Full Text] [Related]
6. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.
Fertleman CR; Baker MD; Parker KA; Moffatt S; Elmslie FV; Abrahamsen B; Ostman J; Klugbauer N; Wood JN; Gardiner RM; Rees M
Neuron; 2006 Dec; 52(5):767-74. PubMed ID: 17145499
[TBL] [Abstract][Full Text] [Related]
7. A nonsense mutation in the SCN9A gene in congenital insensitivity to pain.
Kurban M; Wajid M; Shimomura Y; Christiano AM
Dermatology; 2010; 221(2):179-83. PubMed ID: 20628234
[TBL] [Abstract][Full Text] [Related]
8. Biallelic truncating SCN9A mutation identified in four families with congenital insensitivity to pain from Pakistan.
Sawal HA; Harripaul R; Mikhailov A; Dad R; Ayub M; Jawad Hassan M; Vincent JB
Clin Genet; 2016 Dec; 90(6):563-565. PubMed ID: 27747863
[TBL] [Abstract][Full Text] [Related]
9. Two novel SCN9A gene heterozygous mutations may cause partial deletion of pain perception.
Yuan R; Zhang X; Deng Q; Si D; Wu Y; Gao F; Zhou B
Pain Med; 2011 Oct; 12(10):1510-4. PubMed ID: 21939494
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.
Goldberg YP; MacFarlane J; MacDonald ML; Thompson J; Dube MP; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband HB; Green R; Duff A; Boltshauser E; Grinspan GA; Dimon JH; Sibley BG; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone SN; Samuels ME; Sherrington R; Hayden MR
Clin Genet; 2007 Apr; 71(4):311-9. PubMed ID: 17470132
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in SCN9A in a child with congenital insensitivity to pain.
Shorer Z; Wajsbrot E; Liran TH; Levy J; Parvari R
Pediatr Neurol; 2014 Jan; 50(1):73-6. PubMed ID: 24188911
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain.
Staud R; Price DD; Janicke D; Andrade E; Hadjipanayis AG; Eaton WT; Kaplan L; Wallace MR
Eur J Pain; 2011 Mar; 15(3):223-30. PubMed ID: 20692858
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling.
Remacle AG; Kumar S; Motamedchaboki K; Cieplak P; Hullugundi S; Dolkas J; Shubayev VI; Strongin AY
J Biol Chem; 2015 Sep; 290(38):22939-44. PubMed ID: 26283785
[TBL] [Abstract][Full Text] [Related]
14. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.
Drenth JP; Te Morsche RH; Mansour S; Mortimer PS
Arch Dermatol; 2008 Mar; 144(3):320-4. PubMed ID: 18347287
[TBL] [Abstract][Full Text] [Related]
15. A stop codon mutation in SCN9A causes lack of pain sensation.
Ahmad S; Dahllund L; Eriksson AB; Hellgren D; Karlsson U; Lund PE; Meijer IA; Meury L; Mills T; Moody A; Morinville A; Morten J; O'donnell D; Raynoschek C; Salter H; Rouleau GA; Krupp JJ
Hum Mol Genet; 2007 Sep; 16(17):2114-21. PubMed ID: 17597096
[TBL] [Abstract][Full Text] [Related]
16. A novel nonsense mutation in SCN9A in a Moroccan child with congenital insensitivity to pain.
Mansouri M; Chafai Elalaoui S; Ouled Amar Bencheikh B; El Alloussi M; Dion PA; Sefiani A; Rouleau GA
Pediatr Neurol; 2014 Nov; 51(5):741-4. PubMed ID: 25439579
[TBL] [Abstract][Full Text] [Related]
17. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.
Drenth JP; te Morsche RH; Guillet G; Taieb A; Kirby RL; Jansen JB
J Invest Dermatol; 2005 Jun; 124(6):1333-8. PubMed ID: 15955112
[TBL] [Abstract][Full Text] [Related]
18. Functional confirmation that the R1488* variant in SCN9A results in complete loss-of-function of Na
He W; Young GT; Zhang B; Cox PJ; Cho LT; John S; Paciga SA; Wood LS; Danziger N; Scollen S; Vangjeli C
BMC Med Genet; 2018 Jul; 19(1):124. PubMed ID: 30037327
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.
Dib-Hajj SD; Estacion M; Jarecki BW; Tyrrell L; Fischer TZ; Lawden M; Cummins TR; Waxman SG
Mol Pain; 2008 Sep; 4():37. PubMed ID: 18803825
[TBL] [Abstract][Full Text] [Related]
20. Chronic non-paroxysmal neuropathic pain - Novel phenotype of mutation in the sodium channel SCN9A gene.
Dabby R; Sadeh M; Gilad R; Lampl Y; Cohen S; Inbar S; Leshinsky-Silver E
J Neurol Sci; 2011 Feb; 301(1-2):90-2. PubMed ID: 21094958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
